The Hepatitis B immunisation rate in the US remains stable, with a consistent 91% of children immunised from 2024 to 2028, compared to previous actual data up to 2023. The year-on-year variation indicates no significant change, and the compound annual growth rate (CAGR) over the last five years is also steady at 0%. This suggests that the immunisation efforts are maintaining their effectiveness and reach. It's critical to continue monitoring potential influences, such as policy shifts, public perception of vaccines, and healthcare access, which could impact future immunisation rates.
Future trends to watch for include:
- New policies and their impact on immunisation rates.
- Technological advancements in vaccine delivery.
- Societal and cultural shifts affecting public health priorities.
- Emerging health emergencies that could reallocate resources away from routine immunisation programs.
